SC 13G/A

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Company: Cullinan Therapeutics, Inc.
Filed: February 14, 2022
Accession Number: 0000921895-22-000523

View Document ↗ View on SEC.gov ↗